AKL-T01 2.2 is an investigational digital therapeutic intervention developed by Akili Interactive Labs, Inc. for use on mobile iOS devices. The platform utilizes a consumer-grade action videogame interface to deliver simultaneous cognitive tasks through high-quality graphics and reward mechanisms.
Overview · Full Intel report in progress
The App DNA
What makes this app unique?
For Patients under the direction of a healthcare provider or study doctor participating in clinical investigations.
What does it look like?
Key features
Delivers therapeutic content through a consumer-grade, immersive gaming interface.
Incorporates adaptive, multi-tasking challenges designed for digital intervention.
Utilizes integrated reward systems to facilitate engagement within the digital therapeutic environment.
How much does it cost?
Velocity
Who built it?
Akili Interactive Labs
5 apps tracked · Medical
EndeavorOTC®: Outplay ADHD
EndeavorRx® - Kid
EndeavorRx Insight®
ADHD InsightUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for AKL-T01 2.2
How's the Medical market?
The rivals identified
The Analyst's Read
Key takeaways for AKL-T01 2.2
Where is it heading?
Bottom line
This is an investigational medical device restricted to clinical use and is not intended for personal or consumer use.
Report last updated